Matt Holian 合伙人 Global Co-Chair, Life Sciences Sector firstname.lastname@example.org 电子名片 波士顿 电话: _+1_ 617_ 406_ 6009 传真: _+1_ 617_ 406_ 6109 概述 经验 背景 见解与洞察 电邮 打印 PDF版本 + 分享 Matt Holian serves as the Global Co-Chair of DLA Piper's Life Sciences Sector. Matt's practice focuses on litigation, regulatory and enforcement challenges facing pharmaceutical and medical device companies. His litigation practice primarily involves serving as national counsel in complex, multi-jurisdictional product liability suits, for which DLA Piper's Product Liability and Mass Tort practice group has been recognized by Legal 500 as Tier 1 since 2014 and by Chambers as Band 2 or Band 3 since 2015. In those cases, Matt defends his clients from start to finish, beginning with litigation risk assessments before medications are approved and continuing through pretrial discovery, bellwether trials and, ultimately, resolution. Matt also has litigated cases involving environmental contamination, the False Claims Act, consumer fraud, and commercial disputes relating to licensing agreements. In addition to his litigation practice, Matt also has an active regulatory and enforcement practice, which includes conducting compliance investigations, counseling clients regarding research and development issues (including defending hundreds of claims asserted by patients in clinical trials) and advising life sciences and other clients on a wide range of emerging regulatory issues, such as product labeling, First Amendment challenges to promotional restrictions, real word evidence and value-based contracts.